Edgewise Therapeutics Inc (EWTX) concluded trading on Thursday at a closing price of $29.50, with 11.85 million shares of worth about $349.49 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 75.91% during that period and on September 19, 2024 the price saw a gain of about 54.69%. Currently the company’s common shares owned by public are about 70.45M shares, out of which, 58.46M shares are available for trading.
Stock saw a price change of 67.90% in past 5 days and over the past one month there was a price change of 49.59%. Year-to-date (YTD), EWTX shares are showing a performance of 169.65% which increased to 378.12% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.12 but also hit the highest price of $23.50 during that period. The average intraday trading volume for Edgewise Therapeutics Inc shares is 974.52K. The stock is currently trading 59.99% above its 20-day simple moving average (SMA20), while that difference is up 57.07% for SMA50 and it goes to 79.35% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Edgewise Therapeutics Inc (NASDAQ: EWTX) currently have 70.45M outstanding shares and institutions hold larger chunk of about 71.52% of that.
The stock has a current market capitalization of $2.77B and its 3Y-monthly beta is at 0.16. It has posted earnings per share of -$1.53 in the same period. It has Quick Ratio of 30.24 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EWTX, volatility over the week remained 13.42% while standing at 7.67% over the month.
Stock’s fiscal year EPS is expected to rise by 5.97% while it is estimated to decrease by -26.06% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on March 07, 2024 offering an Overweight rating for the stock and assigned a target price of $48 to it. On August 25, 2022, Goldman Downgrade their recommendations, while on April 13, 2022, RBC Capital Mkts Initiated their ratings for the stock with a price target of $31. Stock get a Neutral rating from Goldman on January 28, 2022.
